Technology News and Research

RSS

Abingworth announces final closing of £225M ($375M) fund

Abingworth, the international investment group dedicated to life sciences and healthcare, today announced the final closing of its £225m ($375m) fund, Abingworth Bioventures VI (ABV VI). ABV VI, Abingworth's 10th life sciences fund, exceeded its target of £200 million and invests in life sciences and healthcare both in Europe and the US.

28 Feb 2014

Yangon General Hospital first to install Varian technology for cancer treatment

Yangon General Hospital has become the first clinical site in Myanmar to install new technology from Varian Medical Systems (NYSE: VAR) for treating cancer with radiotherapy.

28 Feb 2014

Cedars-Sinai neurosurgeon successfully performs CSF repair surgery on patient

When Elizabeth "Beth" Johnson stood up from working at her computer Oct. 28, she noticed "a kind of funny feeling" in the back of her neck. By Nov. 2, the sensation had become an excruciating headache that came on whenever she tried to stand or sit upright.

28 Feb 2014

Online insurance shoppers may soon turn to third-party registration sites

The Washington Post reports that as officials work toward the final enrollment season push, the administration is turning to some private entrepreneurs to help sign up people. Also, the Los Angeles Times examines how many young people are signing up.

28 Feb 2014

FSU researchers study smart technology that can search for autism, communication delays in infants

Someday your doctor may be able to examine your infant, notice a telltale physical characteristic and say, "Your child has autism — but we've caught it early, so don't worry."

28 Feb 2014

UH scientists working to develop next generation of prostate cancer therapies

A University of Houston scientist and his team are working to develop the next generation of prostate cancer therapies, which are targeted at metabolism.

27 Feb 2014

Covidien closes acquisition of Given Imaging

Covidien plc today announced that it has closed its acquisition of Given Imaging Ltd., providing the company additional scale and scope to serve a significant medical specialty, the multibillion dollar global gastrointestinal (GI) market.

27 Feb 2014

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today reported financial results for the three months and year ended December 31, 2013, and provided an update of recent corporate developments.

27 Feb 2014

Adocia reports positive preliminary results for first clinical trial of BioChaperone Combo

Adocia announces today positive preliminary results for the first clinical trial on an innovative formulation combining insulin analog Glargine (Lantus, Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, Lispro (Humalog, Eli Lilly) using Adocia's BioChaperone technology.

27 Feb 2014

Researchers launch new programme to remotely monitor patients undergoing chemotherapy

Researchers from the University of Surrey have today launched a new programme of research called eSMART (Electronic Symptom Management using ASyMS Remote Technology), that uses mobile phone technology to remotely monitor patients who are undergoing chemotherapy to treat breast, bowel and blood cancers.

27 Feb 2014

Cedars-Sinai researchers develop unique imaging device to "light up" malignant brain tumors

Researchers at the Cedars-Sinai Maxine Dunitz Neurosurgical Institute and Department of Neurosurgery have developed a unique, compact, relatively inexpensive imaging device to "light up" malignant brain tumors and other cancers.

27 Feb 2014

Studies indicate that harvested rainwater frequently harbors pathogens

South Africa has been financing domestic rainwater harvesting tanks in informal low-income settlements and rural areas in five of that nation's nine provinces. But pathogens inhabit such harvested rainwater, potentially posing a public health hazard, especially for children and immunocompromised individuals, according to a team from the University of Stellenbosch.

27 Feb 2014

Health exchanges create cybersecurity challenges, hacker opportunities

The Associated Press reports that a number of state health exchanges that were supposed to link to the federal computer system were initially rated as "high risk."

27 Feb 2014

UAB launches pilot program to detect earlier stages of glaucoma

Glaucoma is a silent disease. It does not hurt, symptoms are slow to develop, and most people do not notice any loss of vision until it is too late. A project by ophthalmologists at the University of Alabama at Birmingham will examine whether a partnership with community-based optometrists will improve detection and treatment of glaucoma, especially for high-risk populations.

27 Feb 2014

CCNAP highlights psychological issues related to cardiac diseases

The congress will be held 4-5 April in Stavanger, Norway, at the Stavanger Forum.

26 Feb 2014

Elsevier titles recognized in AJN Book of the Year Awards

...

26 Feb 2014

Griffith Health's Heidi Muenchberger among the recipients of 2014 Australian Fulbright Scholarship

How a building can improve health and healing after injury or illness is the focus of a study by Associate Professor Heidi Muenchberger, a recently announced recipient of the 2014 Australian-American Fulbright Commission Scholarships.

26 Feb 2014

Study: Patients more likely to die in hospitals when cared for by nurses with heavy workloads

Patients are more likely to die after common surgical procedures when they are cared for in hospitals with heavier nurse workloads and fewer nurses with bachelor's degrees, concludes the largest investigation of nursing and hospital outcomes in Europe to date, published in The Lancet.

26 Feb 2014

Study highlights the importance of personalized medicine for treating cancer

If a driver is traveling to New York City, I-95 might be their route of choice. But they could also take I-78, I-87 or any number of alternate routes. Most cancers begin similarly, with many possible routes to the same disease. A new study found evidence that assessing the route to cancer on a case-by-case basis might make more sense than basing a patient's cancer treatment on commonly disrupted genes and pathways.

26 Feb 2014